Social Networks Symposium
Thursday, December 7, 9:00am-2:00pm
Samuel Friedman, PhD - NDRI
Carl Latkin, PhD - Johns Hopkins University
Danielle German, PhD, MPH - Johns Hopkins University
April Young, PhD, MPH - University of Kentucky
NYU Kimmel Center, 60 Washinton Square South
Find more information and register HERE.

AIDS Seminar
Expanded Access, Ethics and Compassionate Use - From Drugs for HIV to Personalized Medicine
Tuesday, December 12, 10:30-11:30am
Arthur Caplan, PhD - NYU Langone Health
NYU Meyers, 433 First Ave, Conference Room 760
Find more information HERE.


NYU Population Health Research Seminar
Developing a Center for TeleHealth Research: A Health Services Research Proposal in Progress
Wednesday, December 6, 12:00pm
Scott Sherman, MD, MPH - NYU Langone Health
NYU Translational Health Building, 227 East 30th Street, Room 120
Find more information HERE.

NYU Langone Health CTSI Seminar
Enhancing Diversity & Inclusion in Research Recruitment & Retention: Strategies and Lessons Learned
Thursday, December 7, 4:00-5:00pm
Bernadette Boden-Albala, PhD, MPH - NYU CGPH
NYU Translational Research Building, 227 East 30th Street, Room 120
Find more information HERE, RSVP required via


Several new reports of interest were released last week:

Some journals of interest have issued calls for papers:

  • American Journal of Public Health for a theme issue on applying methods, metrics, and indicators for measuring disparities in health outcomes and risk behaviors for the prevention and treatment of HIV, STDs, viral hepatitis, and TB in the US. Find more information HERE.
  • Harm Reduction Journal for a new series on the challenges facing gambling harm prevention and reduction, and to provide a range of strategies to prevent and reduce gambling harm. Find more information HERE.


Notice of Intent to Publish a Funding Opportunity Announcement for International Research Collaboration on Drug Abuse and Addiction Research (R01 Clinical Trial Optional)
NIDA intends to reissue the International Research Collaboration on Drug Abuse and Addiction Research to solicit applications that encourages collaborative research applications on drug abuse and addiction that take advantage of special opportunities that exist outside the US. Special opportunities include access to unusual talent, resources, populations, or environmental conditions in other countries that will speed scientific discovery.

Research on Pre-Exposure Prophylaxis (PrEP) to Prevent HIV in Health Disparity Populations (R01 Clinical Trial Not Allowed)
The purpose of this initiative is to support community-based and healthcare setting-based research to understand the individual, interpersonal, community and societal factors that influence patterns of PrEP attitudes, access, availability, and adherence among health disparity populations in the US. Projects may involve primary quantitative and/or qualitative data collection and/or secondary analysis of existing data.

Reissued NIH Funding Opportunities

Clinical Trials or Observational Studies of Behavioral Interventions for Prevention of Opioid Use Disorder or Adjunct to Medication Assisted Treatment-SAMHSA Opioid STR Grants (R21/R33)

Targeted basic behavioral and social science and intervention development for HIV prevention and care (Clinical Trial Optional)

Innovations in Mechanisms and Interventions to Address Mental Health in HIV Prevention and Care Continuum (Clinical Trial Optional)

Formative and Pilot Intervention Research for Prevention and Treatment of HIV/AIDS (R34 Clinical Trial Optional)

Innovations in HIV Testing, Adherence, and Retention to Optimize HIV Care Continuum Outcomes (Clinical Trial Optional)

Targeted Implementation Science to Achieve 90/90/90 Goals for HIV/AIDS Prevention and Treatment (Clinical Trial Optional)

Strengthening the HIV Pre-Exposure Prophylaxis (PrEP) Care Continuum through Behavioral, Social, and Implementation Science (Clinical Trial Optional)

Multidisciplinary Studies of HIV/AIDS and Aging (Clinical Trial Optional)

Multi-Site Studies for System-Level Implementation of Substance Use Prevention and Treatment Services (Clinical Trial Optional)

NIDA Research Center of Excellence Grant Program (P50 Clinical Trial Optional)

NIDA Core "Center of Excellence" Grant Program (P30 Clinical Trial Optional)

Avenir Award Program for Genetics or Epigenetics of Substance Use Disorders (DP1 Clinical Trial Optional)

Mobile Health: Technology and Outcomes in Low and Middle Income Countries (R21 Clinical Trial Optional)

Increased Knowledge and Innovative Strategies to Reduce HIV Incidence-iKnow Projects (R01 Clinical Trial Optional)

Health Services Research on Minority Health and Health Disparities (Clinical Trial Optional)

NIH Pathway to Independence Award (Parent K99/R00)
(Clinical Trial Required)
(Clinical Trial Not Allowed)

Improving Smoking Cessation in Socioeconomically Disadvantaged Populations via Scalable Interventions (Clinical Trial Optional)

Tobacco Use and HIV in Low and Middle Income Countries (Clinical Trial Optional)

Evaluating the NIDA Standardized Research E-Cigarette in Risk Reduction and Related Studies (U01 Clinical Trial Optional)


Giannou F, Nikolopoulos GK, Pantavou K, Benetou V, Kantzanou M, Sypsa V, Williams LD, Friedman SR, & Hatzakis A (2017) Knowledge, normative beliefs and attitudes related to recent HIV infection among people who inject drugs in Athens, Greece. Current HIV Research, doi: 10.2174/1570162X15666171122165636. Find the abstract on the publisher's website HERE.

Goedel WC, Mitchell JW, Krebs P, & Duncan DT (2017) Willingness to use mobile phone apps for HIV prevention among men who have sex with men in London: web-based survey. JMIR Mhealth Uhealth, 5, e153. Find the full, open access article on the publisher's website HERE.

Kostaki E, Magiorkinis G, Psichogiou M, Flampouris A, Iliopoulos P, Papachristou E, Daikos GL, Bonovas S, Otelea D, Friedman SR, Hatzakis A, & Paraskevis D (2017) Detailed molecular surveillance of the HIV-1 outbreak among people who inject drugs (PWID) in Athens during a period of four years. Current HIV Research, doi: 10.2174/1570162X15666171120104048. Find the abstract on the publisher's website HERE.


Harvard Medical School's Department of Population Medicine (DPM) and The Fenway Institute are conducting a joint search for a population studies scientist/health services researcher focused on sexual and gender minority health, who would receive a Harvard appointment at the advanced Assistant or Associate Professor level, and have office space at Fenway Health and DPM. They are looking for someone who would be ready to build a research team, able to use the considerable data resources of both institutions to better understand the socioeconomic, structural, and community-related health disparities experienced by sexual and gender minority people, and to develop culturally tailored interventions to improve population health. Find more information HERE.

Postdoctoral Enrichment Program (PDEP) at the Burroughs Wellcome Fund provides a total of $60,000 over three years to support the career development activities for underrepresented minority postdoctoral fellows in a degree-granting institution (an institution includes its affiliated graduate and medical schools, hospitals and research institutions) in the United States or Canada whose training and professional development are guided by mentors committed to helping them advance to stellar careers in biomedical or medical research. Find more information HERE.

Open Society Foundation’s Public Health Program (PHP) seeks a full-time program officer based in New York to develop and implement grant-making strategies that advance the health and human rights of sex workers and undocumented migrants. The Program Officer collaborates with other colleagues in the PHP and across the Open Society Foundations to support organizations that challenge laws and law enforcement practices that effectively criminalize sex workers and undocumented migrants, that advocate for accessible and adequate health services, and that elevate voices and leadership of marginalized communities. Find more information HERE.


Applications are now being accepted for the Interdisciplinary Research Training Institute on Hispanic Drug Abuse (IRTI) program at the University of Southern California. The program is designed to promote the career development of pre-doctoral, post-doctoral and early career scientists interested in conducting research on drug abuse among Hispanics. The IRTI aims to ensure a formal support infrastructure for fellows to present, publish, and acquire funding for NIH research. Fellows in the program have access to the expertise of leading NIDA researchers and will receive training on topics specific to the socio-behavioral and bio-medical areas of Hispanic Drug Abuse. Find more information HERE.

International AIDS Conference
July 23-27, 2018 - Amsterdam, Netherlands
Abstracts are being accepted through February 5, 2018
The Abstract Mentor Programme has been set up for early stage investigators seeking assistance before submitting an abstract; and they are also calling on more experienced investigators to sign up to serve as mentors.